Targeting IL-5Rα with antibody-conjugates reveals a strategy for imaging and therapy for invasive bladder cancer
Despite the high interest and concern due to an increasing incidence and death rate, patients who develop muscle invasive bladder cancer (MIBC) have few options available. However, the past decade has produced many candidate bladder tumor-specific markers but further development of these markers is...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis Group
2017-10-01
|
| Schriftenreihe: | OncoImmunology |
| Schlagworte: | |
| Online-Zugang: | http://dx.doi.org/10.1080/2162402X.2017.1331195 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
